Filing Flows › NeuroPace (NPCE) › Q2 2026
NeuroPace (NPCE) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
NeuroPace (NPCE) reported revenue of $22.8M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +3% from the quarter before. Operating margin was -22.5%, net loss $6.2M (27.2% of revenue).
NeuroPace, Q2 2026: revenue $22.8M (+17% year over year), operating margin -22.5%, net loss $6.2M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.8M | +3% | +17% |
| Operating profit | −$5.1M | — | — |
| Net earnings | −$6.2M | — | — |
| Operating cash flow | −$3.9M | — | — |
What changed
Revenue was $22.8M in Q2 2026, up 17% year over year and up 3% from the previous quarter.
Gross margin was 82.8%, down 0.3 points from Q2 2025. Operating costs exceeded revenue by $5.1M, an operating margin of -22.5%. Operating expenses fell 1% while revenue rose 17%. The quarter ended with a net loss of $6.2M, narrower than the previous quarter's $6.7M loss.
Operating cash flow was −$3.9M. Non-cash charges added back $100K of depreciation and $2.3M of share-based compensation. Capital expenditures of $125K exceeded it, leaving free cash flow of −$4.0M.
Questions
What was NeuroPace's revenue in the second quarter 2026?
NeuroPace (NPCE) reported revenue of $22.8M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +3% from the quarter before.
Was NeuroPace profitable in the second quarter 2026?
Operating loss was $5.1M (-22.5% of revenue) and net loss $6.2M.
Source: NeuroPace 10-Q on SEC EDGAR.